Clinical Trials Directory

Trials / Completed

CompletedNCT02215694

Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels

Supplementation of Dual Probiotic Strains, Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032, Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels in Nondiabetic and Hypertriglyceridemic Subjects

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
24 Years – 68 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of dual probiotic strains containing Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on triglyceride and apolipoprotein A-V.

Detailed description

A randomized, double-blind, placebo-controlled study was conducted on 128 nondiabetic and hypertriglyceridemic (Plasma Triglyceride, 150-500 mg/dL) subjects. Over a 12 week test period, the probiotic group consumed 2g of powder daily containing dual probiotic strains, while the placebo group consumed the same without probiotics.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdual probiotics2g of powder daily containing dual probiotics(Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032)
DIETARY_SUPPLEMENTplacebo2g of powder daily without probiotics

Timeline

Start date
2012-06-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2014-08-13
Last updated
2014-08-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02215694. Inclusion in this directory is not an endorsement.